Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
Tel: |
021-65675885 18964387627 |
Email: |
customer_service@efebio.com |
Products Intro: |
Product Name:BTA-9881 CAS:1646857-24-0 Purity:99% Package:1mg;5mg;10mg
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:BTA-9881 CAS:1646857-24-0 Purity:99.86% Package:1mg/RMB 558;5mg/RMB 2780;10mg/RMB 4670
|
5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- manufacturers
- BTA-9881
-
- $80.00 / 1mg
-
2025-04-30
- CAS:1646857-24-0
- Min. Order:
- Purity: 99.86%
- Supply Ability: 10g
|
| 5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- Basic information |
Product Name: | 5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- | Synonyms: | AZD-9639;BTA 9881;BTA9881;BTA-9881;MEDI-564;AZD9639;5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)-;BTA 9881,BTA9881 | CAS: | 1646857-24-0 | MF: | C21H15ClN4O2 | MW: | 390.82 | EINECS: | | Product Categories: | | Mol File: | 1646857-24-0.mol | ![5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- Structure](CAS/20210305/GIF/1646857-24-0.gif) |
| 5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- Chemical Properties |
Boiling point | 636.0±55.0 °C(Predicted) | density | 1.51±0.1 g/cm3(Predicted) | solubility | DMSO:0.0(Max Conc. mg/mL);0.0(Max Conc. mM) | pka | 3.46±0.10(Predicted) |
| 5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- Usage And Synthesis |
Uses | BTA-9881 (MEDI-564) is a RSV inhibitor, with an EC50: 48 nM, 59 nM and 160 nM for RSV A2, RSV Long, and RSV B1. BTA-9881 has favorable pharmacokinetics property[1]. | References | [1] Bond S, et al. 1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate. Bioorg Med Chem Lett. 2015 Feb 15;25(4):976-81. DOI:10.1016/j.bmcl.2014.11.024 |
| 5H-Imidazo[1',2':1,2]pyrrolo[3,4-c]pyridin-5-one, 9b-(4-chlorophenyl)-1,2,3,9b-tetrahydro-1-(3-pyridinylcarbonyl)-, (9bS)- Preparation Products And Raw materials |
|